Roxie Oliver-Payne
Family Medicine · Peoria, ILNPI 1376864959
Payments from drug & device makers
Across 235 payments — averaging $22.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$650
- E.r. Squibb & Sons, L.L.C.$402
- Otsuka America Pharmaceutical, Inc.$374
- Vanda Pharmaceuticals Inc.$364
- AbbVie$339
- Neurocrine Biosciences, Inc.$317
- plus $3K from 29 others
What the payments were for
- Food & beverage$5,361100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 23 | $650 |
| E.r. Squibb & Sons, L.L.C. | 10 | $402 |
| Otsuka America Pharmaceutical, Inc. | 19 | $374 |
| Vanda Pharmaceuticals Inc. | 18 | $364 |
| AbbVie | 16 | $339 |
| Neurocrine Biosciences, Inc. | 17 | $317 |
| Bayer | 16 | $283 |
| Abbott | 9 | $279 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $267 |
| Dexcom, Inc. | 4 | $236 |
| Indivior Inc. | 11 | $222 |
| Novartis | 10 | $166 |
| AstraZeneca | 5 | $149 |
| Gilead | 7 | $138 |
| Teva Pharmaceuticals USA, Inc. | 3 | $133 |
| Orexo US, Inc. | 7 | $116 |
| Pfizer | 6 | $103 |
| Lilly USA, LLC | 6 | $99 |
| Sanofi Pasteur Inc. | 4 | $80 |
| GSK | 5 | $73 |
| Merck | 3 | $68 |
| Amgen | 3 | $57 |
| Braeburn Inc. | 3 | $57 |
| Axsome Therapeutics, Inc. | 2 | $52 |
| Organon | 2 | $51 |
| Ironshore Pharmaceuticals Inc. | 3 | $51 |
| Alkermes, Inc. | 2 | $51 |
| Exact Sciences | 2 | $36 |
| Boehringer Ingelheim | 1 | $28 |
| Biogen | 1 | $27 |
| Novo Nordisk | 2 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Insulet Corporation | 1 | $21 |
| Phadia US Inc. | 1 | $12 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$250
- FREESTYLE LIBRE 3$116
- COBENFY$116
- DEXCOM G7 GSS (161)$111
- AUSTEDO$106
How this compares
$5,361 in reported general payments places this provider in the 90th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 88 | $61,518 |
| TrulicityDulaglutide | 57 | $57,633 |
| EliquisApixaban | 67 | $47,198 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 39 | $24,967 |
| FarxigaDapagliflozin Propanediol | 31 | $21,739 |
| JanuviaSitagliptin Phosphate | 35 | $19,418 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 34 | $11,722 |
| Repatha SureclickEvolocumab | 11 | $8,913 |
| KerendiaFinerenone | 13 | $7,670 |
| VascepaIcosapent Ethyl | 21 | $7,281 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 15 | $6,330 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 33 | $5,905 |
| Varenicline Tartrate | 14 | $4,846 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $4,603 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 25 | $2,623 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $28 | $61,51888 claims |
| Lilly USA, LLCTrulicity | $99 | $57,63357 claims |
| PfizerEliquis | $103 | $47,19867 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $73 | $35,89966 claims |
| AstraZenecaFarxiga | $149 | $21,73931 claims |
| MerckJanuvia | $68 | $19,41835 claims |
| BayerKerendia | $283 | $7,67013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Peoria
- David TrachtenbargPeoria$304K
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.